Search for Clinical Trial Results

Sponsored By

Fallopian Tube Diseases - 17 Studies Found

Status Study
Completed Study Name: Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography
Condition: Tubal Obstruction
Date: 2015-11-21
Interventions: Procedure: hysterosalpingography Starting procedure by using largest appropriate speculum for maximum ce
Completed Study Name: Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
Condition:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer Date: 2016-11-22
    Interventions:
    • Procedure: Baseline Biopsy Bas
Completed Study Name: Hysteroscopic Tubal Occlusion Using Iso-Amyl 2-Cyano Acrylate (Amcrylate) in Patients With Hydrosalpinx
Condition:
  • Hydrosalpinx
  • Infertility, Female

Date: 2016-11-23
Interventions: Drug: Isoamyl 2-Cyanoacrylate
Completed Study Name: Use of Essure® Micro-inserts in Women With Hydrosalpinx Prior to In Vitro Fertilization: A Prospective, Multicenter, International Feasibility Study
Condition: Women Who Suffer From Hydrosalpinx That is Causing Infertility and Whom Want a Safer Way of Treamtent
Date: 2010-10-04
Interventions: Device: Essure Micro Insert
Completed Study Name: Prevalence of HbA1C in Women With PCOS
Condition:
  • Polycystic Ovarian Syndrome
  • Pelvic Endometriosis
  • Insulin R
    Date: 2013-04-15
Completed Study Name: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Condition:
  • Gynecologic Neoplasms
  • Epithelial Ovarian Cancer
  • Uterine En
    Date: 2016-03-31
    Interventions: Drug: Pembrolizumab Pembrolizumab 200mg IV Other Nam
Completed Study Name: A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer
Condition:
  • Cancer Ovaries
  • Cancer Peritoneal
  • Cancer, Fallopian Tube Date: 2017-01-13
    Interventions:
    • Drug: OMP-305B83 intravenous (
Not yet recruiting Study Name: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Condition:
  • Advanced Cancer
  • Ovarian Cancer
  • Primary Peritoneal Carcinom
    Date: 2017-01-20
    Interventions:
    • Drug: Pembrolizumab Given intr
Completed Study Name: Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients _MITO-23
Condition: Ovarian Neoplasms
Date: 2016-08-26
Interventions:
  • Drug: Trabectedin Other Name:

Completed Study Name: A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
Condition:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer Date: 2016-06-29
Next >>>